Abrogated transforming growth factor beta receptor II (TGFRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis

Dirk Lievens, Kim L. Habets, Anna-Karin Robertson, Yasmina Laouar, Holger Winkels, Timo Rademakers, Linda Beckers, Erwin Wijnands, Louis Boon, Munir Mosaheb, Hafid Ait-Oufella, Ziad Mallat, Richard A. Flavell, Mats Rudling, Christoph J. Binder, Norbert Gerdes, Erik A. L. Biessen, Christian Weber, Mat J.A.P. Daemen, Johan KuiperEsther Lutgens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3717-3727
JournalEuropean Heart Journal
Volume34
Issue number48
DOIs
Publication statusPublished - Dec 2013

Keywords

  • Atherosclerosis
  • Inflammation
  • TGF
  • Dendritic cell

Cite this

Lievens, D., Habets, K. L., Robertson, A-K., Laouar, Y., Winkels, H., Rademakers, T., Beckers, L., Wijnands, E., Boon, L., Mosaheb, M., Ait-Oufella, H., Mallat, Z., Flavell, R. A., Rudling, M., Binder, C. J., Gerdes, N., Biessen, E. A. L., Weber, C., Daemen, M. J. A. P., ... Lutgens, E. (2013). Abrogated transforming growth factor beta receptor II (TGFRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. European Heart Journal, 34(48), 3717-3727. https://doi.org/10.1093/eurheartj/ehs106